Industry News · Live

What's moving the medical supply market.

Curated from medtech publications. Product launches, FDA clearances, M&A, technology shifts — rewritten as short briefs, linked back to the source. Filter by theme below.

Live
Stories
0
Sources
0
Updated
0hours ago
Feed · products
§001New productsApril 24, 2026

Imricor begins US commercial sales of NorthStar mapping system

Imricor Medical Systems has launched commercial sales of its NorthStar Mapping System in the US market. The system is designed for cardiac electrophysiology procedures, enabling real-time mapping and navigation during ablation and other interventional cardiac treatments. The commercial rollout follows regulatory clearance and positions Imricor to compete in the cardiac mapping and navigation device segment.

Source · Medical Device NetworkRead brief
§002New productsApril 21, 2026

Sentante’s breakthrough telesurgery system could redefine stroke care

Sentante, a robotics startup, announced a telesurgery system designed for endovascular stroke intervention. The platform aims to address a market gap, as endovascular medicine currently lacks a commercially dominant robotic surgical platform. CEO Edvardas Satkauskas highlighted unmet clinical needs in the specialty that the system targets.

Source · Medical Design & OutsourcingRead brief
§003New productsApril 20, 2026

Freudenberg Medical launches ISO Class 5 cleanroom for biopharma

Freudenberg Medical announced CleanAssure, a new ISO Class 5 controlled cleanroom facility for processing sterile single-use assemblies in biopharma manufacturing. The service combines cleaning and sterilization capabilities to deliver ready-to-use components to customers, expanding Freudenberg's contract manufacturing and design offerings in the single-use systems market.

Source · Medical Design & OutsourcingRead brief
§004New productsApril 20, 2026

How ZB’s Paragon 28 created a novel curved foot nail system

Zimmer Biomet's Paragon 28 division has launched a novel curved foot nail system designed to better match foot and ankle anatomy. The implant required development of three new instruments alongside the device itself. The innovation addresses surgical fixation for foot and ankle procedures.

Source · Medical Design & OutsourcingRead brief
§005New productsApril 17, 2026

The first year-long CGM implant developer isn’t done yet

Senseonics launched Eversense 365, the first implantable continuous glucose monitor (CGM) designed to function for a full year, in 2024. Unlike transcutaneous rivals from Abbott and Dexcom that use small needles to measure interstitial glucose, the Eversense system uses a different sensing approach. The company is advancing the implantable CGM category as a differentiated alternative in the glucose monitoring market.

Source · Medical Design & OutsourcingRead brief
§006New productsApril 15, 2026

MiniMed flexes with next-gen insulin pump after spinning off from Medtronic

MiniMed, recently spun off from Medtronic via March IPO, secured FDA clearance for its next-generation MiniMed Flex automated insulin delivery system. The screenless, compact pump represents a product advancement for the standalone diabetes-device company and signals continued R&D investment in its core insulin-delivery portfolio following the separation from its former parent.

Source · Medical Design & OutsourcingRead brief
§007New productsApril 14, 2026

BMF launches clear resin for transparent micro 3D printing

Boston Micro Fabrication introduced BMF Clear resin, enabling optical transparency in micro-precision 3D printing. The material addresses manufacturing gaps for microfluidic devices and optical components, enabling applications such as direct printing of micro-lenses onto fiber optic tips and sensor surfaces. The resin expands scalable production options for previously difficult-to-manufacture medical device components.

Source · Medical Design & OutsourcingRead brief
§008New productsFebruary 4, 2026

Hims & Hers to sell Grail’s Galleri multi-cancer blood test via its digital health platform

Hims & Hers, a telehealth platform, has begun offering Grail's Galleri multi-cancer blood test through its digital health service. Galleri is a cell-free DNA screening test designed to detect multiple cancer types from a single blood draw. The partnership expands access to the test via Hims & Hers' existing patient base and distribution channels, marking a move by the telehealth vendor into cancer screening diagnostics.

Source · Fierce HealthcareRead brief
§009New productsSeptember 10, 2025

Apple aims to catch 1 million hypertension cases in one year with new Apple Watch

Apple launched a blood pressure monitoring feature on its latest Apple Watch model, designed to detect hypertension cases at scale. The feature uses the existing pulse-rate sensor to measure blood vessel response to heartbeats. Apple projects the capability could identify approximately 1 million undiagnosed hypertension cases within the first year of deployment, positioning the device as a consumer-grade screening tool for cardiovascular risk.

Source · Fierce HealthcareRead brief